Appeal court grants Genentech's growth market to Novo Nordisk

被引：0

|

作者：

Kling, J

机构：

[1] an independent science writer working in Bellingham,

来源：

NATURE BIOTECHNOLOGY | 1997年 / 15卷 / 05期

关键词：

D O I：

10.1038/nbt0597-403a

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：403 / 403

页数：1

相关论文

共 50 条

[1] Appeal court grants Genentech's growth market to Novo Nordisk
Jim Kling
Nature Biotechnology, 1997, 15 : 403 - 403
[2] BLR update: Genentech v. Novo Nordisk
不详
BIOTECHNOLOGY LAW REPORT, 1997, 16 (5-6): : 599 - 600
[3] Preliminary injunction in Novo Nordisk v Genentech vacated by CAFC
Bent, SA
BIOTECHNOLOGY LAW REPORT, 1996, 15 (02): : 228 - 228
[4] BLR UPDATE - GENENTECH TO APPEAL OSAKA COURT DECISION ON TPA
不详
BIOTECHNOLOGY LAW REPORT, 1995, 14 (03): : 426 - 427
[5] District court grants U California's motion to dismiss patent infringement suit by Genentech
不详
BIOTECHNOLOGY LAW REPORT, 1997, 16 (01): : 69 - 70
[6] Novo Nordisk's Medical Miracle
Langreth, Robert
FORBES, 2011, 187 (03): : 78 - +
[7] Novo Nordisk's environmental accountability
Pistorius, R
BIOTECHNOLOGY AND DEVELOPMENT MONITOR, 1997, (33) : 16 - 19
[8] EFSD, JDRF and Novo Nordisk announce 8 grants of Euro 100,000
Diabetologia, 2006, 49 (2) : 424 - 430
[9] More on Genentech v. Novo Nordisk - CAFC invalidates biotechnology patent on appeal from grant of preliminary injunction; Demands complete enablement; Submarine patents likely to be adversely affected
Jacobs, AL
BIOTECHNOLOGY LAW REPORT, 1997, 16 (04): : 437 - 441
[10] Novo Nordisk's reply to call for withdrawal of liraglutide
Moses, Alan
BRITISH MEDICAL JOURNAL, 2012, 344

← 1 2 3 4 5 →